Satsuma Pharmaceuticals Inc. buy BiotechBee
Start price
08.09.22
/
50%
€6.30
Target price
31.12.24
€8.00
Performance (%)
-88.33%
End price
14.12.22
€0.74
Summary
This prediction ended on 14.12.22 with a price of €0.74. The BUY prediction by BiotechBee for Satsuma Pharmaceuticals Inc. performed very badly with a performance of -88.33%. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Satsuma Pharmaceuticals Inc. | - | - | - |
iShares Core DAX® | 2.594% | -1.158% | 14.782% |
iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% |
iShares Nikkei 225® | 0.687% | -8.354% | 18.454% |
iShares S&P 500 | 2.209% | -0.942% | 31.361% |
According to BiotechBee what are the pros and cons of Satsuma Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Satsuma Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 8,0
In the thread Trading Satsuma Pharmaceuticals Inc.
Buy beendet